share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Davis Robert M

SEC announcement ·  Feb 15 16:03
Summary by Moomoo AI
Merck & Co's Chairman, CEO & President, Davis Robert M, completed a series of stock transactions on February 13 and 14, 2024. The executive sold a total of 235,021 shares of common stock at prices ranging from $125.3993 to $126.3733, resulting in a total market value of $29,538,998.07. Prior to the sales, Davis acquired the same number of shares through the exercise of derivative securities at prices between $73.73 and $75.36. Following these transactions, Davis Robert M's direct holdings in Merck & Co amounted to 348,326.757 shares of common stock.
Merck & Co's Chairman, CEO & President, Davis Robert M, completed a series of stock transactions on February 13 and 14, 2024. The executive sold a total of 235,021 shares of common stock at prices ranging from $125.3993 to $126.3733, resulting in a total market value of $29,538,998.07. Prior to the sales, Davis acquired the same number of shares through the exercise of derivative securities at prices between $73.73 and $75.36. Following these transactions, Davis Robert M's direct holdings in Merck & Co amounted to 348,326.757 shares of common stock.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more